CS | EN
Monday, June 12, 2017

Artios signs research collaboration with MU to develop novel cancer treatments

Artios _logoCambridge, UK, 12 June 2017. Artios Pharma Ltd., a leading DNA Damage Response (DDR) company developing innovative new treatments for cancer, today announces it has signed a research collaboration and option agreement with Masaryk University MU in the Czech Republic for the development of novel cancer treatments targeting DNA nucleases involved in the DDR.

Read the whole press release here.